BE AWARE OF UNAUTHORISED AGENCIES PRETENDING TO PROVIDE OFFICIAL SERVICES USING THE ESCRS BRAND

The official registration and housing bureau for the ESCRS iNovation® Day 2022 is MCI Suisse SA and you should only trust information from legitimate sources like the ESCRS website, congress website, and MCI website.

It is important to be aware that you may be contacted by phone or e-mail, or see advertising, by unauthorised individuals or companies that act as travel agencies, wholesalers, or destination management companies to solicit you with aggressive or deceptive tactics for congress registrations.

They may also misrepresent themselves as the official congress registration and housing bureau and may illegally use the congress name or logo. Please be aware that such companies do not represent ESCRS or MCI and are not mandated to act on their behalf.

If you are contacted by someone asking if you need to register to the ESCRS iNovation® Day 2022 or need a room, please do not complete your registration and/or room booking with such entities and do not process any of the payments they may request.

Registrations purchased in this manner will not give access to the ESCRS iNovation® Day 2022.

If possible, please obtain as much information as you can, such as the name of the company, the person calling and their telephone number — then contact MCI Suisse SA at escrs.inovation.reg@mci-group.com. Should you require further information or want to confirm the legitimacy of any deals or services related to the congress, please feel free to get in touch with us.

DO YOU WANT TO RECEIVE THE LATEST ESCRS NEWS?

Complete your details below to sign up to the ESCRS meetings and events newsletter

RECEIVE THE LATEST NEWS

Please watch this very important video message from the ESCRS President Prof. Oliver Findl

Why you should join us at the 2022 iNovation Day

Attendance Options

A safe environment for in-person interaction

Grow your Network

Networking opportunities with 500 clinical and business experts

Stay in the Know

Learn about latest developments in the European commercial and capital markets, projected 2023 innovations,
regulatory changes, and reimbursement trends